Anxiety disorders affect people worldwide with disabling symptoms. Xylopic acid, an entkaurane diterpene, exerts central nervous system depressant, opioid receptor-mediated analgesic and anti-neuropathic pain effects. Agents acting as CNS depressants can ameliorate anxiety disorders hence, this study evaluates the anxiolytic potential of xylopic acid in mice and zebrafish. Xylopic acid was given orally at 3, 10 or 30 mg kg 
Introduction
Although anxiety is a common emotional activity, it can usually switch into an overdrive and result in a prolonged devastating psychiatric syndrome and reduce overall quality of life Kaurane diterpenes have been shown to exhibit central nervous system effects including anticonvulsant 6 and neuroprotective effects 7 . Xylopic acid is a kaurane diterpene that has been 8 and central analgesic effects 9 as well as ameliorative effects against chemotherapy-induced neuropathic pain 10 . CNS-acting drugs may be useful in managing more than one CNS disorders 11, 12 . For example the anticonvulsant gabapentin, is used to treat neuropathic pain and anxiety whereas the antidepressant duloxetine is also used in chronic pain and anxiety management 13 . It is therefore possible that xylopic acid having shown anti-neuropathic pain and other CNS effects may exhibit additional anxiolytic effects. This contribution therefore explores the anxiolytic potential of xylopic acid in response to the continued search for novel pharmacological options for anxiety disorder management. 
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Materials and Methods
Animals
Drugs and Chemicals
Desipramine, diazepam and pentylenetetrazole and were obtained from Sigma-Aldrich, St Louis, MO, USA.
Extraction and Characterization
Xylopic acid (Fig 1a) was extracted from the fruits (unripe and dried) of Xylopia aethiopica (Dunal) A. Rich (Annonaceae) as previously described by Woode and colleagues (2012) 14 . The isolated xylopic acid was purified by recrystalization with a reflex condenser. It was characterized and the purity confirmed by HPLC-HRESI-MS (Fig 1b) . (unprotected and protected head dipping) was captured by the aid of a camera fixed ~50 cm overhead. These behaviours in the 5-minute test were independently scored by an experienced observer using JWatcher TM . Ethovision Version XT 10 was used to evaluate the total distance trekked and also create activity heat maps of locomotion within the maze.
Hyponeophagia Test
The novelty-induced hyponephagia test described by Dulawa and colleagues was modified and used 17 . Mice in groups of ten 
Chimney Test
Effect of xylopic acid on locomotor activity and neuromuscular co-ordination was assessed with chimney test as previously described 18 . Xylopic acid-treated mice (3, 10 30 mg kg -1 ) were allowed to climb backwards in a vertical-placed transparent glass cylinder (2.8 cm 30 cm). Motor impairment was recorded as inability to complete the challenge in 60 s.
Zebrafish Models of Anxiety
Novel Tank (NT) Test
This test was performed as earlier on described by Levine and colleagues with slight differences 19 . The apparatus is a slender glass chamber (15 10 
Scototaxis Test (Dark Preference Test)
The innate inclination of zebrafish to stay in dark areas was 
Alcohol Withdrawal-induced Anxiety
The activity of XA on anxiety induced after alcohol withdrawal was evaluated in zebrafish as per protocol previously ) or distilled water for 30 minutes. This was repeated for 3 days as described above. Twenty four hours after the last drug treatment, the novel tank test was performed as elaborated above.
Data Analysis
Data was analyzed blindly of group treatments. Results indicate group mean ± SEM with P<0.05 deemed statistically significant. Where, Y is the response (from bottom (a) to top (b) with a sigmoid profile and X is the logarithm of dose. The F test was employed to compare various ED50s.
Results
Open Field Test
When mice were freely allowed to explore the novel brightly lit arena, there was an increase in total duration in the corner zone and a reverse scenario in the center zone as indicated by mice in the control group (Fig 2a, b) . Xylopic acid treatment reduced this trend significantly at 30 mg kg -1 although less potent than diazepam (Fig 2c) (F8, 60 = 33.66 P<0.001) as did DZP. The PTZ group showed increased activity in the corner and reduced total time in the center of the arena (Fig 2g) .
Xylopic acid as well as diazepam dose-dependently increased exploration as shown by the increased total distance trekked (Fig 2h) (F10, 44 = 5.683 P<0.001) . Similarly, xylopic acid-treated mice exhibited reduced thigmotactic activity as revealed by the activity heat maps as little or no activity along the wall of the arena (Fig 2e) .
Hyponeophagia Test
Xylopic acid significantly reversed novelty suppressed feeding as exhibited by an increase in weight of food consumed in the 5 min test period (F3,35 = 4.923 P = 0.0169). It also reduced the latency to feeding at all doses tested (F3,35 = 17.04 P < 0.001) (Fig 3a, b) . 
Fig 2: Xylopic acid displays anxiolytic effects in the open field test in mice
Elevated Plus Maze Test
The EPM evoked anxiogenic responses in mice as exhibited by reduced open arm duration in control and PTZ-treated mice. This was however attenuated by both xylopic acid (F6,58) = 6.48 P <0.001) and diazepam (F6,58 = 7.495 P <0.001) treatments (Fig   4a, b) . Heat maps revealed increased activity in open arms for xylopic acid-treated mice in contrast to control groups (Fig 4c-f) .
Xylopic acid reduced risk assessment behaviours similar to DZP.
Both protected head dips and protected stretch-attend postures (SAPs) were minimized significantly by XA and DZP (Fig 4 g, h) . 
Chimney Test
Xylopic acid at all the doses tested did not impair neuromuscular coordination in mice. All mice completed the chimney test challenge under 60 s.
Novel Tank Test
In the NT test, naïve zebrafish demonstrated anxiety-like behaviours by exhibiting a significant increase in both latency to explore top section and the total duration spent at the lowest region of the tank. However, zebrafish administered with 30 µM XA exhibited decreased latency to explore the upper region (F3, 39 = 1.329, P = 0.0236) (Fig 5a) in addition to spending more in the top region (F7, 38 = 9.861, P < 0.001) (Fig 5b) . Similar effect was observed in DES-treated zebrafish (F3, 37 = 6.348, P <0.001).
Scototaxis Test
In the scototaxis test, the naïve zebrafish preferred dark regions.
In contrast to desipramine that ameliorated this anxiety-related observation at 300 µM (F7, 38 = 17.86, P < 0.001) (Fig 6) , XA could not overturn this preference. 
Fig 4: Xylopic acid reduces ethological endpoints of anxiety in EPM test in mice
Alcohol withdrawal-induced anxiety
Ethanol withdrawal evoked an anxiogenic response mirrored as the increase in bottom dwelling and increased latency to top region in untreated zebrafish in the control group (Fig 7) .
Xylopic acid however attenuated this resulting in increased time spent at the top and a converse decrease latency to top segment. Similar effects were observed in diazepam treated group.
Discussions
We have employed a battery-style methodology of different models of anxiety disorders in two species and present here, 
Fig 6: Xylopic acid does not reduces scototaxis in zebrafish
Effects of XA (3, 10, 30 µM) and DES (10, 30, (snugging to the walls) and decreased duration of time used in exploring the "anxiety provoking" center of the OFT apparatus 22, 24 .
In this regard, efficacious anxiolytics calm this aversion and enhance the exploratory activity in anxiogenic zones 22 . Thus, the fact that both diazepam, an established anxiolytic and the investigational agent xylopic acid, enhanced total duration of exploration of the center zone in addition to decreasing thigmotaxis is an indication of possible anxiolytic-like effects. This suspicion is further corroborated by xylopic acid-treated mice increasing the average velocity and total distanced traveled in the OFT arena, an indication of increased exploration and for that matter increased overall anxiety of that animal.
To further check the anxiolytic-like properties of xylopic acid in the OFT, the novelty-induced hyponeophagia test was carried out.
This test exploits a conflict between an anxiogenic provocation and hunger-induced approach behaviour 25, 26 . antagonists did not avert dark preference in adult zebrafish although they demonstrate anxiolytic behaviors in other models 42 .
It has been hypothesized that other mechanisms may be significantly involved in the scototaxis model of anxiety in zebrafish 39 and therefore can be conveniently speculated that xylopic acid may not rely on such pathways in exhibiting the anxiolytic properties observed so far. This lack of anxiolytic-like response in the scototaxis test in zebrafish could be overlooked by the fact that, xylopic acid exhibited anxiolytic-like properties in another zebrafish model of anxiety induced by alcohol withdrawal.
When regular consumption of alcohol is ceased in human 43 , rodents 44 and zebrafish 45 withdrawal symptoms related to exaggerated anxiety is observed. In zebrafish models, there is enhanced bottom dwelling, erratic movement, and delayed latency to explore near-surface regions when alcohol exposure is abruptly withdrawn 46, 47 . All these signatures of anxiety behaviors induced by alcohol withdrawal were ameliorated by xylopic acid which leads further credence to the fact that the kaurane diterpene, xylopic acid, has anxiolytic-like properties in mice and zebrafish. 
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